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biotics that has evolved in bacteria since the introduction of
these compounds in clinical treatments (1–5). The ability of
M␤Ls to hydrolyze the amide bond of the ␤-lactam ring characteristic of this group of antibiotics depends on the presence of
one or two Zn(II) ions bound to their active sites (2, 5). M␤Ls
display an unusually broad substrate profile and are not susceptible to clinically used inhibitors of the well known serine-␤lactamases. Increasingly frequent reports of transmission of
M␤L genes among pathogenic and opportunistic bacteria indicate that bacteria expressing these enzymes pose a significant
threat to public health (3).
The design of therapeutically useful inhibitors for these
enzymes has been unsuccessful so far. The diverse substrate
preferences of M␤Ls may preclude the discovery or design of a
universal inhibitor with both efficacy and specificity toward all
M␤Ls. Despite extensive study, there is still great controversy
regarding the metal content in the catalytically relevant species
and on the mechanisms of action of M␤Ls (2, 6 –13). The elusive nature of intermediates and transition states during the
reaction has hampered rational inhibitor design. This scenario
prompts for a detailed characterization of the different active
species and their metal content in the resting state form and
during turnover.
BcII, the M␤L from Bacillus cereus, has been extensively
characterized, thus representing a prototypical enzyme for
mechanistic studies. BcII was first crystallized with only one
Zn(II) ion tetrahedrally coordinated to three His residues
(His116, His118, and His196) and an H2O/OH⫺ molecule (14), in
the so-called 3H site (14) (Fig. 1A). Spectroscopic experiments
(10) and a second crystal structure later indicated that BcII was
also capable of binding a second metal ion (15, 16), which is
trigonal bipyramidally coordinated to Asp120, Cys221, His263, a
H2O/OH⫺ bridging the two metal ions, and an additional water
molecule. This site is known as the DCH site (Fig. 1B). Further
spectroscopic studies revealed that when the apoenzyme is
reconstituted with 1 eq of Zn(II), Cd(II), or Co(II), the metal ion
is distributed between both binding sites, instead of following
an ordered, sequential binding (8, 10, 17, 18). In addition, some
of these data suggested that formation of the dinuclear species
takes place only at a metal/BcII ratio larger than 1 (8). Knowing
His116, His118, and His196; DCH site, metal binding site composed of ligands
Asp120, Cys221, and His263; MF, Mag-fura-2; CT, charge transfer; NOE,
nuclear Overhauser effect; NOESY, NOE spectroscopy.
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Metallo-␤-lactamases are zinc-dependent enzymes that constitute one of the main resistance mechanisms to ␤-lactam antibiotics. Metallo-␤-lactamases have been characterized both in
mono- and dimetallic forms. Despite many studies, the role of
each metal binding site in substrate binding and catalysis is still
unclear. This is mostly due to the difficulties in assessing the
metal content and site occupancy in solution. For this reason,
Co(II) has been utilized as a useful probe of the active site structure. We have employed UV-visible, EPR, and NMR spectroscopy to study Co(II) binding to the metallo-␤-lactamase BcII
from Bacillus cereus. The spectroscopic features were attributed
to the two canonical metal binding sites, the 3H (His116, His118,
and His196) and DCH (Asp120, Cys221, and His263) sites. These
data clearly reveal the coexistence of mononuclear and
dinuclear Co(II)-loaded forms at Co(II)/enzyme ratios as low as
0.6. This picture is consistent with the macroscopic dissociation
constants here determined from competition binding experiments. A spectral feature previously assigned to the DCH site in
the dinuclear species corresponds to a third, weakly bound
Co(II) site. The present work emphasizes the importance of
using different spectroscopic techniques to follow the metal
content and localization during metallo-␤-lactamase turnover.

Metal Binding to B. cereus Metallo-␤-Lactamase BcII
assigned to the DCH site in the dinuclear species correspond to
a third, weakly bound Co(II) site, 2) a di-Co(II) species is formed
at a Co(II)/BcII ratio as low as 0.6, and 3) different species coexist in equilibrium at very low (⬍1) Co(II)/BcII ratios. These
observations prompt for a reinterpretation of previous studies
on Co(II)-substituted BcII and suggest that the catalytic mechanism of this enzyme cannot be analyzed without considering
the different coexisting species.

the identity of the metallated species formed at increasing
metal concentration is specially important if we recall recent
studies that suggest that Co(II)-BcII is only active in its
dinuclear form (19).
Metal binding studies on the homologous M␤L CcrA from
Bacteroides fragilis have shown a different metal binding mechanism (20). Co(II) uptake by apo-CcrA was strictly sequential, as
shown by several spectroscopic techniques. At a Co(II)/CcrA ratio
equal to 1, only the 3H site becomes occupied, whereas the DCH
site is metallated upon the addition of a second Co(II) equivalent.
No evidence of redistribution (“scrambling”) of the metal ion
between the two binding sites was found for this enzyme (20).
Co(II) can be exploited as a unique spectroscopic probe of
the catalytic mechanism of M␤Ls by following its spectral features during turnover (7, 21, 22). We decided to characterize in
detail the identity and metal content of the Co(II)-BcII adducts
formed at different Co(II)/BcII ratios prior to any mechanistic
study. By using UV-visible, EPR, and NMR spectroscopy, as
well as through measurements of the Co(II) binding constants,
we have determined that 1) BcII is able to bind up to 3 Co(II) eq
in its active site and that some of the features previously
OCTOBER 19, 2007 • VOLUME 282 • NUMBER 42
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FIGURE 1. Active sites of mono-Zn(II) BcII (A) and di-Zn(II) BcII (B). The
images were rendered with PyMol (DeLano Scientific LLC) from Protein Data
Bank files 1bmc and 1bc2, respectively. Zinc atoms are rendered as large
spheres, and solvent molecules are rendered as small spheres.

EXPERIMENTAL PROCEDURES
Reagents—All chemicals were of the highest quality available.
The MTPBS buffer was 16 mM Na2HPO4, 4 mM NaH2PO4, and
150 mM NaCl, pH 7.3. Escherichia coli BL21(DE3)pLysS⬘ cells
(Stratagene) were employed for protein production. Luria-Bertani (LB) medium (Sigma) was used as growth medium for all
bacterial strains.
DNA Techniques and Cloning Procedure—DNA preparation
and related techniques were performed according to standard
protocols (23). Plasmid DNA was isolated using the Wizard
Plus SV Minipreps kit (Promega).
Enzyme Purification—Wild type BcII was expressed in E. coli
BL21(DE3)pLysS⬘ as a fusion protein with glutathione S-transferase (10), purified, and quantified as follows. Typically, the
cell pellet obtained from 50 ml of a culture in late logarithmic
phase in LB medium supplemented with 150 g/ml ampicillin
and 35 g/ml cloramphenicol was resuspended in fresh
medium and used to inoculate 1 liter of LB medium supplemented with 150 g/ml ampicillin and 35 g/ml cloramphenicol in a 5-liter Erlenmeyer flask. Cells were grown for 2 h at
37 °C until A600 ⫽ 1 was reached. The expression of fusion
protein was induced by the addition of 10 g of lactose, and the
culture was further incubated at 37 °C for an additional 4-h
period. All subsequent purification steps were performed at
4 °C. E. coli cells were disrupted by sonication in lysis buffer
(MTPBS with 3.3 g/ml DNase, 5 mM MgCl2, and 1 mM phenylmethylsulfonyl fluoride), and cell debris was separated by
ultracentrifugation. The GST-BcII fusion protein was purified
by affinity chromatography using a glutathione-Sepharose
resin (Amersham Biosciences), as previously reported (10). The
pure fractions were treated with bovine plasma thrombin
(Sigma) at a 1:100 ratio, after the addition of 150 mM NaCl, 2.5
mM CaCl2, at 26 °C for 2 h. BcII was purified from the proteolysis mixture by ion exchange chromatography on Sephadex
CM-50 (Amersham Biosciences) as previously reported (10).
Protein samples were dialyzed against ⬎100 volumes of 10 mM
HEPES, pH 7.5, 0.2 M NaCl. Purity of the enzyme preparations
was checked by SDS-PAGE. Protein concentration was measured spectrophotometrically using ⑀280 ⫽ 30,500 M⫺1 cm⫺1
(18). Metal content in protein samples was checked using the
colorimetric reagent 4-(2-pyridilazo)-resorcinol and ranged
between 1.4 and 1.8 metal/total protein, depending on the
enzyme preparation (24, 25).
Preparation of Apo-BcII—All buffer solutions used to prepare the apoenzyme were treated by extensive stirring with
Chelex 100 (Sigma). Apo-BcII was prepared by dialysis of the
purified holoprotein (⬃200 M) against two changes of ⬎100
volumes of 10 mM HEPES, pH 7.5, 0.2 M NaCl, 20 mM EDTA
over a 12-h period. EDTA was removed from the resulting

Metal Binding to B. cereus Metallo-␤-Lactamase BcII

Mono-Co(II)BcII º apo-BcII ⫹ Co(II) KD1
Di-Co(II)BcII º Mono-Co(II)BcII ⫹ Co(II) KD2
Tri-Co(II)BcII º Di-Co(II)BcII ⫹ Co(II)
KD3
MODEL 1

The model assumes that the mono-Co(II) species is a mixture of
two enzyme species, one with cobalt bound to the 3H site (which
absorbs at 550 nm) and a second species with metal bound to the
DCH site (which absorbs at 343 nm). Di-Co(II) BcII presents both
metal binding sites loaded and absorbs at 550 and 343 nm, and the
tri-Co(II) species absorbs at 550 nm and at 383 nm.
Metal Binding Affinities Measured with Mag-fura-2—The
dissociation constants were estimated from competition experiments with the chromophoric chelator Mag-fura-2 (MF;
Molecular Probes, Eugene, OR) (8). The indicator was first
titrated with Co(II) at 30 °C, and changes in absorbance at 363
nm with added metal were fit with DynaFit to obtain the dissociation constant of Co(II) from the complex with Mag-fura-2
(KMF) in 100 mM HEPES, pH 7.5, 0.2 M NaCl. A value of 2.8 ⫾
0.1 M was obtained, with ⑀MF, 363 nm ⫽ 22,000 ⫾ 100 M⫺1 cm⫺1
and ⑀Co(II)䡠MF, 363 nm ⫽ 4,510 ⫾ 140 M⫺1 cm⫺1. Afterward, a
solution of 2.7 M Mag-fura-2 in 100 mM HEPES, pH 7.5, 0.2 M

30588 JOURNAL OF BIOLOGICAL CHEMISTRY

NaCl was titrated with Co(II) in the presence of 1–3 M apoBcII, using a 1.12 mM CoSO4 stock solution in the same buffer,
at 30 °C. The changes in absorbance at 363 nm with added
metal, obtained from experiments carried out with three different apoprotein concentrations, were fit together to two different models, using the program DynaFit, in order to calculate
KD1 and KD2. The first model (Model 2, described below)
involves three dissociation equilibria, where KMF was fixed to
the value determined independently.
Co(II).MF º Co(II) ⫹ MF
KMF
Mono-Co(II)BcII º apo-BcII ⫹ Co(II)
KD1
Di-Co(II)BcII º Mono-Co(II)BcII ⫹ Co(II) KD2
MODEL 2

A second model involving four dissociation equilibria
(Model 3, presented below), was also considered. KMF and KD3
were fixed to the values determined independently, from Co(II)
binding to MF and from the UV-visible titration of apo-BcII
with Co(II), respectively.
Co(II).MF º Co(II) ⫹ MF
Mono-Co(II)BcII º apo-BcII ⫹ Co(II)
Di-Co(II)BcII º Mono-Co(II)BcII ⫹ Co(II)
Tri-Co(II)BcII º Di-Co(II)BcII ⫹ Co(II)

KMF
KD1
KD2
KD3

MODEL 3

EPR Spectroscopy—EPR spectroscopy was performed at
either 13 K, 2 milliwatts, and 9.63 GHz (Bmicrowave ⬜ Bstatic) or
10 K, 50 milliwatts, and 9.37 GHz (Bmicrowave 储 Bstatic), using a
Bruker Elexsys E500 spectrometer equipped with an ER 4116
DM TE012/TE102 dual mode X-band cavity and an Oxford
Instruments ESR-900 helium flow cryostat. EPR spectra were
simulated with the matrix diagonalization program XSophe
(Bruker Biospin) using a spin Hamiltonian H ⫽ ␤g䡠H䡠S ⫹ S䡠D䡠S ⫹
S䡠A䡠I Least-squares fitting of simulations and experimental
spectra was carried out using IGORPro (Wavemetrics).
Recording conditions of 13 K and 2 milliwatts were determined
to be nonsaturating for 0.5, 1.0, and 2.0 eq of Co(II) in frozen
solutions of BcII. Integration of spectra thus recorded gave
pseudoabsorption curves that lay on a level base line, providing
further strong evidence that there were no selectively saturated
species in the spectra of BcII with 1 and 2 eq of Co(II). Spectra
recorded at up to 160 milliwatts and down to 3.6 K provided no
evidence at all for any species with very fast relaxation, and the
spectra under these conditions were typical for spectra of MS ⫽
1⁄2 Co(II) under rapid passage conditions.
The apoprotein samples (⬃1 mM), in 100 mM HEPES, pH 7.5,
0.2 M NaCl, were titrated stepwise with a 6 mM CoSO4 stock
solution prepared in the same buffer. The Co(II)-containing
solution was rapidly mixed with the sample in the EPR tube by
manual flicking (27) and frozen in liquid nitrogen. For successive additions of Co(II), EPR samples were quickly thawed (⬃5
s) from 77 K to 20 °C by agitating the sample tube in water.
NMR Spectroscopy—NMR spectra were recorded on a
Bruker Avance II 600 spectrometer operating at 600.13 MHz at
different temperatures, as indicated. 1H NMR spectra were
recorded under conditions set to optimize detection of the fast
VOLUME 282 • NUMBER 42 • OCTOBER 19, 2007

Downloaded from http://www.jbc.org/ at MARQUETTE UNIV on April 4, 2017

apoenzyme solution by three dialysis steps against ⬎100 volumes of 10 mM HEPES, pH 7.5, 1 M NaCl, 0.3 g/liter Chelex 100;
one dialysis step against ⬎100 volumes of 10 mM HEPES, pH
7.5, 0.2 M NaCl, 0.3 g/liter Chelex 100; and finally two dialysis
steps against ⬎100 volumes of 100 mM HEPES, pH 7.5, 0.2 M
NaCl, 0.3 g/liter Chelex 100. All dialysis steps were carried out
at 4 °C, under stirring and for at least 6 h. Metal content in
apoprotein samples was checked using the colorimetric reagent
4-(2-pyridilazo)-resorcinol (24, 25).
Electronic Spectroscopy of Co(II)-BcII Derivatives—A solution of 200 –300 M apo-BcII in 100 mM HEPES, pH 7.5, 0.2 M
NaCl was titrated with a 10.6 mM CoSO4 stock solution prepared in 100 mM HEPES, pH 7.5, 0.2 M NaCl. Spectra were
recorded at room temperature in a Jasco 550 UV-visible spectrophotometer. The spectra were corrected for dilution upon
adding Co(II), and the UV-visible difference spectra were
obtained by subtracting the spectrum of apo-BcII.
The complete formation of the di-Co(II) adduct, as monitored by UV-visible spectroscopy, was achieved at a ratio of
1.4 –1.8 Co(II)/total protein, depending on the enzyme preparation. In all preparations, the level of Co(II) uptake of the
apoenzymes paralleled the original Zn(II) content of the protein as
isolated. The concentration of “metallable” protein was then calculated by multiplying the concentration of protein determined by
absorbance at 280 nm by the factor n/2, where n is the number of
analytical Co(II) equivalents needed to reach the maximum intensity of the d-d (550 nm) and CT (343 nm) bands. At this Co(II)
concentration, all of the metallable protein is in the dinuclear form.
The protein concentration used in the different fits was then calculated by employing this correction factor, to account for the
variable fraction of protein capable of binding metal.
The changes in absorbance at 343, 383, and 550 nm with
increasing Co(II) concentrations were fit simultaneously using
the program DynaFit (BioKin, Ltd.) (26). The data were fit to the
following model (Model 1).

Metal Binding to B. cereus Metallo-␤-Lactamase BcII

relaxing paramagnetic resonances, using either the superWEFT pulse sequence (28) or water presaturation. Spectra
were acquired over large spectral widths with acquisition times
ranging from 16 to 80 ms and intermediate delays from 2 to 35
ms. One-dimensional experiments with solvent presaturation
were used to record isotropically shifted signals closer to the
diamagnetic envelope. T1 measurements were performed using
the nonselective inversion-recovery method. One-dimensional
NOE difference and NOESY spectra were obtained as described
previously (29, 30), with mixing times of 5 and 25 ms.
The apoprotein samples (⬃1 mM), in 100 mM HEPES, pH 7.5,
0.2 M NaCl, were titrated stepwise with a 37.8 mM CoSO4 stock
solution prepared in the same buffer. Co(II) was added to the
sample in the NMR tube. In order to obtain the spectra of the
protein with excess Co(II) in D2O, the sample with 3.5 eq of
added cobalt was diafiltrated with 100 mM HEPES, pH 7.1 (pD
OCTOBER 19, 2007 • VOLUME 282 • NUMBER 42

7.5), 0.2 M NaCl, containing the same concentration of Co(II) as
the protein sample, in Amicon-Ultra-4 units (Millipore). A second titration was carried out in D2O, with the apoprotein sample in 100 mM HEPES, pH 7.1 (pD 7.5), 0.2 M NaCl, by the
stepwise addition of Co(II) from a 37.8 mM stock solution prepared in the same buffer.
No evidence of protein denaturation or aggregation was
detected in any of the titration experiments (UV-visible, EPR,
and NMR), even when working at high protein concentrations.

RESULTS
Spectrophotometric Titrations—The spectrum of Co(II)-substituted BcII with excess Co(II) is reported in the inset in Fig. 2A
(dashed line); it presents two charge transfer bands at 343 and
383 nm (8) and a pattern of ligand field bands (530 – 640 nm)
similar to the one reported for the alkaline form of Co(II)-carJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Determination of the affinity of apo-BcII for Co(II). A, UV-visible titration of 351 M apo-BcII with 10.6 mM CoSO4 in 100 mM HEPES, pH 7.5, 0.2 M NaCl. Molar
absorption values were calculated considering the concentration of protein capable of binding metal (263 M), as described under “Experimental Procedures.” The
inset shows the spectra of di-Co(II) BcII (achieved in this experiment upon the addition of 1.5 Co(II) eq; solid line) and of BcII with excess Co(II) (4.0 Co(II) eq; dashed line).
B, plot of the absorbance at 343 nm (circles), 383 nm (inverted triangles), and 550 nm (squares) as a function of the concentration of added Co(II) in the UV-visible titration.
The solid lines correspond to the fit using Model 1 (see “Experimental Procedures”). C, titration of a solution containing 0.89 M apo-BcII and 2.66 M Mag-fura-2 with
Co(II) in 100 mM HEPES, pH 7.5, 0.2 M NaCl, 30 °C. D, plot of the absorbance at 363 nm as a function of the concentration of added Co(II) for different competition
experiments; the Mag-fura-2 concentration was ⬃2.7 M in both experiments, and the apoprotein concentration was 0.89 M (inverted triangles) and 2.21 M (circles).
The solid line corresponds to the fit using Model 2. The parameters obtained were KD1 ⫽ 0.12 ⫾ 0.06 M, KD2 ⫽ 0.16 ⫾ 0.04 M, ⑀MF, 363 nm ⫽ 22,000 ⫾ 100 M⫺1 cm⫺1,
and ⑀Co(II)䡠MF, 363 nm ⫽ 4,510 ⫾ 140 M⫺1 cm⫺1. The fit obtained with Model 3 (dashed line) superimposes with the curve obtained with Model 2. The parameters obtained
with Model 3 were KD1 ⫽ 0.10 ⫾ 0.06 M, KD2 ⫽ 0.17 ⫾ 0.04 M, ⑀MF, 363 nm ⫽ 22,000 ⫾ 100 M⫺1 cm⫺1, and ⑀Co(II)䡠MF, 363 nm ⫽ 4,510 ⫾ 140 M⫺1 . cm⫺1, with KD3 fixed in 94 M.
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species with metal bound to the DCH site (which absorbs at 343
nm). Di-Co(II) BcII presents both metal binding sites loaded
and therefore absorbs at the same wavelengths, and a tri-Co(II)
species is invoked that absorbs at 550 and 383 nm. From this
experiment, we estimated the following macroscopic dissociation constants: KD1 ⬍ 60 nM, KD2 ⫽ 0.6 ⫾ 0.2 M, KD3 ⫽ 94 ⫾
12 M. This experiment, as a previous related study (8), was
performed at stoichiometric conditions for the first two binding sites and therefore cannot be used to retrieve accurate values for KD1 and KD2. Nevertheless, it reveals the existence of a
spectrophotometrically detectable event with a dependence on
Co(II) that can be described by an apparent equilibrium constant of around 90 M.
Cobalt(II) Binding to BcII by Competition Experiments—We
studied Co(II) binding to apo-BcII by competition experiments
with the chromophoric metal ligand Mag-fura-2, whose spectroscopic features change upon Co(II) binding. This procedure
has already been employed to monitor Zn(II) and Cd(II) binding to apo-BcII (8). The spectra show an isosbestic point at 343
nm and maxima at 363 and 323 nm for the metal-free compound and the 1:1 Co(II) complex, respectively (Fig. 2C). The
titration data could be accounted for by considering a model
with two binding equilibria (Model 2), resulting in submicromolar dissociation constants (KD1 ⫽ 0.12 ⫾ 0.06 M and KD2 ⫽
0.16 ⫾ 0.04 M; Fig. 2D). The competition experiments of apoBcII with Mag-fura-2 could also be fit to a model involving
three equilibria (Model 3) (i.e. taking into account the third
metal ion bound to BcII). However, since the constant for the
third equilibrium (KD3), as estimated from the UV-visible titration, is almost 34 times larger than the dissociation constant of
Co(II) to Mag-fura-2, this third binding site is incapable of competing with Mag-fura-2 for Co(II), and KD3 cannot be estimated
from these competition experiments. Consequently, we
decided to fit the competition data with the three-equilibrium
model but fixing the KD3 value to the one determined from the
UV-visible titration. With this assumption, it is possible to
obtain values for the macroscopic dissociation constants KD1
and KD2 in the context of a model where three Co(II) ions bind
to the enzyme. This model yielded constants KD1 ⫽ 0.10 ⫾ 0.06
M and KD2 ⫽ 0.17 ⫾ 0.04 M (Fig. 2D). These experiments
provide reliable KD values for the two strongly bound Co(II) eq,
being consistent with the weaker binding of a third Co(II), as
suggested by the spectroscopic data.
EPR Titration—The perpendicular mode (Bmicrowave ⬜
Bstatic) EPR spectra observed upon the addition of Co(II) to
apo-BcII (Fig. 3A) were found, by difference analysis, to be linear combinations of up to four components. These “basis species” were, in each case, obtained by subtraction of one experimental species from another, as detailed in the legend to Fig. 3B,
and subsequent computer simulation (Fig. 3C) verified that
they corresponded to single EPR species and provided spin
Hamiltonian parameters. The experimental spectra were
reconstructed (Fig. 3A) as linear combinations of the basis spectra by using a least-squares fitting routine. Examination of the
spin densities of each of the basis species as a function of added
Co(II) indicates that two of the basis species became saturated
(i.e. reached a maximum intensity) during the titration (Fig. S1),
and these are assigned to BcII-bound Co(II). The dominant BcII
VOLUME 282 • NUMBER 42 • OCTOBER 19, 2007
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bonic anhydrase (31). These spectral features have been previously assigned to each of the metal binding sites in BcII. Davies
and Abraham (32) early attributed the 343 nm absorption band
to a ligand to metal charge transfer band due to the interaction
of Co(II) with the Cys ligand in the DCH site. Later, a hybrid
adduct was obtained, in which Zn(II) occupies the 3H site and
Co(II) is located in the DCH site (10). This experiment demonstrated that the absorption features in the visible range are
largely due to the 3H site, whereas the 343 nm band corresponds to the DCH site. A study performed under different
conditions reported a new CT band at 383 nm (8). The authors
attributed this band to the diCo(II)-BcII adduct while assigning
the 343 nm band to a mononuclear form of the enzyme.
Titration of apo-BcII with Co(II) was followed by absorption
spectroscopy in the UV-visible range (Fig. 2, A and B). The
simultaneous buildup of the charge transfer band at 343 nm and
of the d-d bands at ⬍1 eq of Co(II) added confirms that, under
these experimental conditions, the two metal sites are being
filled at the same time, as already reported (8, 10) (Fig. 2, A and
B). Saturation of both bands took place at a Co(II)/BcII ratio
higher than 1 (ranging between 1.4 and 1.8, depending on the
enzyme preparation), in contrast to the data reported by de
Seny et al. (8), where saturation occurs at 1 Co(II) eq per BcII.
At concentrations of added Co(II) beyond this saturation
point, three interesting features are observable in the data presented in Fig. 2B. The intensity of the band at 343 nm decreases
asymptotically, and this is mirrored in an asymptotic increase in
the intensity of the band at 383 nm, although neither of the
intensities of the 343 and 383 nm bands plateaued completely,
even at 4 eq of added Co(II). The third feature of note is that
there is no significant change in the intensity of the d-d region
of the spectrum. These spectral changes can be accounted for
by the binding of Co(II) to BcII in a site that (i) exhibits higher
than 4-fold coordination (with poorly resolved low intensity
d-d bands) and (ii) perturbs the Co(II) ion already bound to the
Cys ligand.
The fact that the d-d bands in the visible range (attributable
to the 3H site) do not increase significantly with further Co(II)
added after saturation of the 343 nm CT band clearly indicates
that both metal sites are fully loaded at this point. Therefore,
the spectrum obtained at this point corresponds to the
di-Co(II) enzyme (Fig. 2A), as originally suggested by us (10).
We used the point of saturation to calculate the effective metallable enzyme concentration, as described under “Experimental Procedures.” From now on, the Co(II) eq refer to the corrected protein concentration. The CT band at 383 nm, which
appears at higher Co(II)/BcII ratios would correspond to a third
metal ion that perturbs the 343 nm signal (DCH site) without
affecting the spectral features of the 3H site. The intensity of the
383 nm CT band was variable among different protein preparations, showing no correlation with the level of metal uptake to
the dinuclear binding site.
The absorbance changes upon Co(II) uptake at 343, 383, and
550 nm could be fit to a model assuming binding of 2 Co(II) eq
at a submicromolar range and a third one with lower affinity
(see Model 1). The model assumes that the mono-Co(II) species
is a mixture of two enzyme species, one with Co(II) bound to
the 3H site (which hence absorbs only at 550 nm) and a second
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species at low [Co(II)] became saturated upon the addition of 0.8 Co(II)
eq, and the EPR signal (Fig. 3C, trace
A) was simulated, assuming S ⫽ 3⁄2,
MS ⫽ 兩⫾ 1⁄2典, D ⬎⬎ h (50 cm⫺1 was
used), E/D ⫽ 0.11, gx,y ⫽ 2.36, and
gz ⫽ 2.44; this EPR signal is denoted
the “axial” signal due to the low E/D
and consequent poor resolution of
the geff.(x,y) resonances. The second
species, termed “rhombic” (Fig.
3C, trace B), was simulated assuming S ⫽ 3⁄2, MS ⫽ 兩⫾ 1⁄2典, D ⬎⬎ h
(50 cm⫺1 was used), E/D ⫽ 0.17,
gx,y ⫽ 2.525, gz ⫽ 2.65, and
AI ⫽ 7⁄2(59Co) ⫽ 8.8 ⫻ 10⫺3 cm⫺1.
The intensity of the rhombic signal
peaked at around 2 eq of added
Co(II) (Fig. S1). A third species, the
“broad” species (Fig. 3C, trace C;
FIGURE 3. EPR spectroscopic titration of apo-BcII with Co(II). A, experimental EPR spectra of BcII were recorded as E/D ⫽ 0.14, gx,y ⫽ 2.22, gz ⫽ 2.22),
a function of added Co(II) and are shown with computer simulations overlaid. Intensities are shown normalized for was isolated by difference; the difCo(II) concentration. Simulations were generated by least-squares linear combinations of the theoretical spectra ference analysis indicated that this
shown as traces A, B, and D of panel C, and the amounts of each species required by the fitting procedure are
illustrated in Fig. S1. B, difference EPR spectra generated during titration of BcII with Co(II). Traces A show overlaid species was not observed until the
spectra of BcII with 0.43 eq of Co(II), with that of BcII with 0.09 eq of Co(II) multiplied by 4.9. Trace B is the difference addition of ⬎2 Co(II) eq, but in the
of the spectra in A (i.e. 0.43 eq minus 0.09 eq ⫻4.9). Trace B is shown multiplied by a factor of 3. Analogously, traces
C are of BcII with 0.83 eq of Co(II) and 0.43 eq of Co(II) (⫻1.74), and trace D is the difference of spectra in C (⫻3). Traces least-squares fitting procedure, its
E are of BcII with 1.69 eq of Co(II) and 0.83 eq of Co(II) (⫻0.98), and trace F is the difference of the spectra in E (⫻3). inclusion was not statistically justiTraces G are of BcII with 2.44 eq of Co(II) and 1.69 eq of Co(II) (⫻1.49), and trace H is the difference of the spectra in G fied. The fourth species observed
(⫻3). Traces I are of BcII with 3.24 eq of Co(II) and 2.44 eq of Co(II) (⫻0.82), and trace J is the difference of the spectra
in I (⫻3). C, computer simulations of EPR spectra and difference spectra. Traces A–D each show experimental and (Fig. 3C, trace D; E/D ⫽ 0.09, gx,y ⫽
computer simulated spectra overlaid. The experimental spectra in A–D correspond to BcII with 0.19 eq of Co(II) (A), 2.26, gz ⫽ 2.28) did not saturate with
trace F of B (1.69 eq ⫺ 0.83 eq) (B), trace H of B (2.44 eq ⫺ 1.69 eq) (C), and trace J of Fig. 3B (3.24 eq ⫺ 2.44 eq) (D). The
added Co(II), and, indeed, the signal
theoretical spectra A, C, and D were simulated assuming a spin Hamiltonian H ⫽ ␤g䡠H䡠S ⫹ S䡠D䡠S, with S ⫽ 3⁄2, an axial
greal, and D ⬎⬎ h (a value of 50 cm⫺1 was used, implying that only the MS ⫽ 兩⫾ 1⁄2典 doublet was appreciably intensity increased steadily beyond
populated). A hyperfine term (S䡠A䡠I) was included in the spin Hamiltonian for the theoretical spectrum of B, to the addition of 2 eq of Co(II). The
account for the I ⫽ 7⁄2 59Co nuclear spin interaction. The resulting EPR parameters were gx,y ⫽ 2.36, gz ⫽ 2.44, E/D ⫽
0.11 (A); gx,y ⫽ 2.525, gz ⫽ 2.65, E/D ⫽ 0.17, A ⫽ 8.8 ⫻ 10⫺3 cm⫺1 (B); gx,y ⫽ 2.22, gz ⫽ 2.22, E/D ⫽ 0.135 (C); and similarity of this signal to those
gx,y ⫽ 2.26, gz ⫽ 2.28, E/D ⫽ 0.09 (D).
from Co(II) in buffers and in
systems including nonspecifically
bound Co(II) suggested that it may not be due to specifically
bound Co(II), and we term the signal “free.”
A closer examination of the EPR data reveals some interesting phenomena. First, the overall spin density detected by perpendicular mode EPR does not correspond to the amount of
Co(II) added (Fig. 4). Up until 0.8 Co(II) eq, the EPR-detected
spins increase linearly with added Co(II) and are due to
increases in the axial and rhombic signals. Between 0.8 and 1.6
Co(II) eq, however, the overall spin density shows only very
little increase in intensity, due to the slow increase in the rhombic signal as Co(II) is added. These data indicated EPR-silent
Co(II) and were highly suggestive of the formation of a spincoupled dinuclear site. Parallel mode (Bmicrowave 储 Bstatic) EPR
was recorded and derivative-shaped signals were observed with
geff. ⬃ 10 (Fig. 5), consistent with a spin-coupled state (S⬘ ⫽ 0, 1,
2, 3) of two Co(II) ions. In these signals, the complete line was
observable, and, thus, the intensities could be related to the
relative amount of this species by simple fitting to a Gaussian
FIGURE 4. EPR spectrometric titration of apo-BcII with Co(II). EPR-detected line and integration of the Gaussian function. The parallel
Co(II) (solid circles) was quantified by double integration of EPR spectra with mode signal appears at around 0.6 eq of Co(II) and increases
respect to Co(II) in 50% 10 mM HEPES buffer, pH 7.5, 50% glycerol. The dashed
line corresponds to the expected behavior where all added Co(II) is essentially linearly between 0.6 and 1.6 eq of Co(II) (Fig. S2).
EPR-detectable.
Taken together with the observation that the axial and rhombic
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FIGURE 5. Representative parallel mode EPR spectra of BcII upon addition
of Co(II). The left panel shows some experimental first derivative parallel
mode EPR spectra of BcII upon titration with Co(II). The right panel shows the
corresponding absorption spectra, generated by integration of the experimental data. The absorption spectra are shown overlaid with a Gaussian function in each case.

species together account for only 40% of the expected spin density after the addition of 1.6 Co(II) eq (and that the free signal
accounts for only another 13%), the parallel mode data provide
compelling evidence for a spin-coupled dinuclear species in BcII.
This clearly demonstrates that the dinuclear form of the enzyme
starts accumulating at Co(II)/enzyme ratios lower than 1.
NMR Titration—The titration of apo-BcII with Co(II) was
followed by 1H NMR spectroscopy at 600 MHz at conditions
that allow detection of paramagnetically shifted signals (Fig. 6)
(33). The spectrum obtained upon the addition of 2 Co(II) eq
has been already reported and includes resonances corresponding
to metal ligands of the 3H and DCH sites (10). Here we report a
spectrum recorded under different conditions (pH 7.5 and low
ionic strength) that resembles the one recorded at pH 6.0 and high
ionic strength (10). The signal assignments for this spectrum,
chemical shifts, and T1 values are summarized in Table 1.
The most downfield-shifted signal envelope centered at 170
ppm is resolved as two separate, broad resonances (A and B) at
higher temperatures (Fig. 6A) and can be assigned to the ␤-CH2
of Cys221 based on their chemical shifts and line widths (20, 30,
34 –39). Resonances D–F are absent when the spectrum is
recorded in D2O. An additional resonance corresponding to an
exchangeable proton (resonance C) can be detected at lower pH
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FIGURE 6. 1H NMR spectra of Co(II)-BcII. A, the spectrum was recorded at 600
MHz, pH 7.5, and 301 K in 100 mM HEPES buffer, 0.2 M NaCl. The inset at the left
shows the most downfield region with the ␤-CH2 Cys resonances recorded at
301 K (bottom) and 318 K (top). The inset at the right shows the 50/30 ppm
region of the spectrum recorded at 318 K, where signal G⬘ is partially resolved.
B, 1H NMR titration of apo-BcII with Co(II). 1H NMR spectra recorded at 600
MHz, pH 7.5, and 301 K in 100 mM HEPES buffer, 0.2 M NaCl, at different Co(II)/
BcII ratios. The 100/30 ppm and 240/100 ppm spectral regions correspond to
spectra recorded using a superWEFT pulse sequence with recycle times of 70
and 10 ms and intermediate recovery delays of 25 and 5 ms, respectively, and
were processed with line broadenings of 100 and 600 Hz, respectively. The
30/18 ppm spectral region corresponds to spectra recorded with water presaturation and recycle times of 200 ms and was processed with line broadenings of 50 Hz. Signals X, Y, D, E, and F were not observed when a similar
titration was performed in D2O solution.

values, as already reported (10). Signals C–F can be attributed
to imidazolic NHs from the His ligands based on their absence
in D2O and chemical shifts (20, 30, 34 –38). Signal E presents an
VOLUME 282 • NUMBER 42 • OCTOBER 19, 2007
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TABLE 1
Spectral parameters and assignments of the hyperfine-shifted
signals of Co(II)-substituted BcII at 301 K in 100 mM HEPES, pH 7.5,
0.2 M NaCl, unless indicated
Signal
A
B
Ca
D
E
F
G
G⬘c
H
I
J
K
a
b
c

␦

T1

ppm

ms

173
168
73
73.7
63.0
43.7
41.2
42
24.4
23.4
22.4
20.2

⬍0.1
⬍0.1
NDb
7
7
7
10
ND
20
20
20
30

Assignment
H␤1 (H␤2) Cys221
H␤2 (H␤1) Cys221
H␦1 His116/196
H␦1 His196/116
H⑀2 His118
H␦1 His263
DCH site
H␦2 His118
H␤1 (H␤2) Asp120
DCH site
DCH site
H␤2 (H␤1) Asp120

Detected at pH 6.
ND, not determined.
Resolved at 318 K.
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DISCUSSION
Metallo-␤-lactamases from different subclasses display
different metal requirements for function. B2 lactamases are
mono-Zn(II) enzymes (40 – 42), whereas enzymes from subclasses B1 and B3 are fully active in the dimetallic form.
Wommer et al. have suggested that the mono-Zn(II) form
would be the only biologically relevant species for enzymes
BcII, BlaB (B1), CphA (B2), and L1 (B3) (6). However, it has
been shown that L1 requires two Zn(II) ions to fold properly
in vivo (43), and other recent kinetic studies indicate that
di-Co(II) BcII would be the only active species (19). All of
these contrasting findings indicate the need for establishing
the metal ion requirements for catalysis. Here we have
employed different complementary strategies and techniques to monitor Co(II) binding to apo-BcII to gain insight
into the metallated species being formed.
Competition experiments with Mag-fura-2 allowed us to
retrieve reliable dissociation constants for 2 Co(II) eq, both
being in the submicromolar range. UV-visible spectroscopy
reveals that, when the intensities of the bands assigned to these
two sites become saturated, a new species accumulates. This
species presents a third Co(II) ion bound to a site with submillimolar affinity that perturbs the Co(II) ion at the DCH site, as
revealed by a shift in the CT band. Based on these three dissoJOURNAL OF BIOLOGICAL CHEMISTRY
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NOE with a resonance at 42 ppm, slightly shifted and broader
than resonance G. Spectra recorded at higher temperatures
allow the detection of a new resonance (G⬘), partially overlapping with signal G at 301 K (Fig. 6A), that is the one showing the
dipolar connectivity with signal E. A reciprocal NOE on signal E
was observed when irradiating at 42 ppm. Based on this evidence, we assign resonance G⬘ to a slowly exchangeable imidazolic CH. Analysis of the crystal structure of BcII reveals that
His118 is bound to the metal ion through its N␦1, whereas
His116, His196, and His263 are coordinated by their N⑀2. Thus,
resonances E and G⬘ can be assigned to the H⑀2 and H␦2 from
His118, respectively. Signals C, D, and F therefore correspond to
the H␦1 of the remaining His ligands. Without any further connectivity, we are unable to obtain the sequence-specific assignment of these resonances.
A NOESY experiment revealed that signals H and K are
strongly coupled, and K is dipolarly coupled to a resonance at 11
ppm (Fig. S3). The ␤-CH2 and ␣-CH of Asp120 are good candidates for these resonances. The rest of the resonances show no
other connectivities and remain unassigned but will be attributed to the 3H or to the DCH site according to the metal site
occupancy, as discussed below.
The 1H NMR spectrum of the species resulting from the
addition of 1 Co(II) eq to apo-BcII exhibited the same set of
resonances present in the di-Co(II) adduct (Fig. 6B) (i.e. corresponding to both sites), in contrast with the situation reported
for B. fragilis CcrA (20). Based on this, we performed a titration
starting at substoichiometric ratios.
Detection of the Cys resonances A and B could be achieved at
a Co(II)/BcII ratio as low as 0.2 (Fig. 6B), indicating that the
DCH site is being occupied at very low Co(II)/protein ratios, in
agreement with the presence of a Cys-Co(II) CT band in the
UV-visible titration under these conditions. The set of resonances H–K at 30 –20 ppm, some of which correspond to
Asp120, as well as signals F and G, were also present at a 0.2
Co(II)/BcII ratio. Two further resonances (X and Y) at 59.0 and
47.4 ppm that are not present at 2 Co(II) eq, were detected at
Co(II)/BcII ratios from 0.2 to 0.6. When a similar titration was
performed in D2O, neither of these resonances was observed,
indicating that they correspond to exchangeable protons.

The intensity of all of the resonances observed at 0.2 Co(II)/
BcII increases with the further addition of Co(II). A new set of
signals is only noticeable beyond 0.6 eq of added Co(II). From
this point onward, the exchangeable His resonances D and E
can be clearly detected, in line with the disappearance of signals
X and Y. For the rest of the titration, the number of detected
signals remains the same.
The NMR titration reveals that resonances corresponding to
the DCH site (ligands Cys221 and Asp120) grow steadily from
0.2 to 2.0 Co(II) eq, without significant chemical shift perturbations. This is not the case for the signals arising from the 3H site.
This suggests that the DCH site is formed in the early steps of
the titration with the same structural features present when 2
Co(II) eq are added. Based on this, we feel confident in attributing resonances F and G to the DCH site and therefore assign
signal F to the H␦1 of His263. By exclusion, resonance D corresponds to the H␦1 of His116 or His196 (3H site).
Resonances X and Y from 0.2 to 0.6 Co(II) eq can be attributed to imidazolic NHs of the His ligands in a distorted 3H site
that rearranges at higher Co(II)/BcII ratios to adopt the final
conformation, giving rise to signals D and E. The other two
resonances attributed to the 3H site (C and G⬘) cannot be
observed under these conditions. However, the NMR titration
shows two clearly distinct behaviors for the 3H and the DCH
sites at ⬍0.6 Co(II)/BcII ratios.
It is worth mentioning that the 1H NMR spectra of Co(II)BcII at different stoichiometric ratios, temperature, and pH values, for all preparations, showed a low signal-to-noise ratio
compared with the one that should be expected for a Co(II)substituted protein under these experimental conditions. This
suggests the existence of a population of Co(II)-BcII with resonances broadened beyond detection that we tentatively attribute to an exchange broadening phenomenon.
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revealed by the EPR titration. This strongly suggests that resonances X and Y correspond to the mono-Co(II)䡠3H BcII and
that D and E are resonances of the 3H site in the di-Co(II)
species. The resonances attributed to ligands of the DCH site
(A, B, and F–K) are unperturbed along all of the titration. Since
EPR reveals no significant di-Co(II) species being formed at
very low Co(II)/BcII ratios, this suggests that the DCH site is
structurally identical in the mono-Co(II) and di-Co(II) species.
It is not surprising that changes in the 3H site are not reflected
in different d-d patterns in the visible spectra, since NMR is
much more sensitive to structural changes than optical
spectroscopy.
Finally, from 2 eq of Co(II) onward, a new EPR signal
develops, the broad signal. Simultaneously, the diminution
in the intensity of the 343 nm electronic absorption band,
with the concomitant growth of a band at 383 nm, indicates
that the further addition of Co(II) perturbs the DCH site.
These data altogether strongly support binding of a third
Co(II) at a weaker site.
In summary, the spectroscopic titrations suggest two bona
fide metal binding sites in BcII. These two sites together form a
dinuclear center with a very small energy difference between an
uncoupled state and a very weakly spin-coupled state. Another
species with a third Co(II) ion bound, which selectively alters
the DCH site, can be formed when excess Co(II) is added. Here
we clearly show that at low Co(II)/BcII ratios, there are at least
three Co(II)-loaded BcII species (mono-Co(II)䡠3H, monoCo(II)䡠DCH, and di-Co(II) BcII). In the case of the homologous
enzyme CcrA from B. fragilis, the addition of 1 Co(II) eq gives
rise to a single, mono-Co(II) species with the metal ion located
in the 3H site (20).
Our picture differs significantly from the one depicted by de
Seny et al. (8) on Co(II)-BcII based on UV-visible data. The
differences are largely attributable to the approach in estimating the KD values. Our model is strongly supported by EPR data,
which allows us to follow the formation of a dinuclear site, and
NMR, which provides the identity of the metal ligands at the
different metal/BcII ratios explored. Overall, this study implies
a new scenario in terms of the metal-loaded species present at
different Co(II)/BcII ratios. This prompts for a reevaluation of
the proposed catalytic mechanisms for Co(II)-BcII (19, 21, 22,
44, 45).
The present study clearly shows that following reaction
kinetics under steady state conditions at different metal/enzyme ratios may be misleading, since the identity of the metalloaded forms may remain undefined. Thus, non-steady-state
kinetic studies and different spectroscopic techniques should
be exploited to follow the metal content and localization during
MBL turnover. Experiments are under way to address this issue.
The metal content of MBLs in vivo is still an unsolved issue
(6), particularly when metal ion availability is compromised.
Here we have shown that different metallated species can coexist at low metal ion concentrations in vitro, and the same situation may hold in the bacterial host. Thus, this scenario should
be considered when elucidating the catalytic mechanism or
designing potential inhibitors.
VOLUME 282 • NUMBER 42 • OCTOBER 19, 2007
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ciation constants, the expected populations of the different
Co(II)-loaded species can be calculated (Fig. S4). The first and
second eq bind with affinities similar to those reported by de
Seny et al. for Zn(II) and Cd(II) binding using the same
approach (8). The proximity of these binding constants indicates that the mono-Co(II) and di-Co(II) species coexist over a
wide range of Co(II)/BcII ratios. Instead, de Seny and co-workers informed a dissociation constant of 66.7 M for the second
Co(II) eq, as determined from the UV-visible titration (8). This
value resulted from the assumption that the growth of the
charge transfer band at 383 nm (Fig. 2A) was due to formation
of di-Co(II) BcII. Here we have shown that this event takes place
after uptake of ⬃2 Co(II) eq/mol of BcII, thus reflecting the
binding of a third Co(II) ion to the enzyme with a dissociation
constant around 90 M.
This complex metal binding scheme is best explored by
examining the data collected over distinct regions of added eq
of Co(II). The UV-visible titration shows that, upon the addition of Co(II), amounts well below 1 eq of metal ion, features
corresponding to both the 3H and the DCH site are present.
Di-Co(II) BcII is expected to be formed at ⬍1 Co(II)/enzyme,
according to the values of KD1 and KD2 here reported (Fig. S4).
Since the features of the 3H and DCH site in the UV-visible
spectra are similar in the mono- and dinuclear species, it is clear
that we cannot resort to the spectrophotometric titration to
fully address the issue of site occupancy under conditions of
limited availability of Co(II).
At Co(II)/BcII ratios of ⱕ0.6, NMR signals attributable to the
3H and to the DCH site are detected, in agreement with the
UV-visible data. The low intensities of the parallel mode EPR
signals and the invariance of the positions of the NMR peaks
between 0 and 0.6 eq of Co(II) suggest that the majority of
Co(II) ions are magnetically and electronically isolated (i.e. that
BcII is largely in one of two mononuclear states, monoCo(II)䡠DCH BcII or mono-Co(II)䡠3H BcII). The axial signal
detected in EPR spectra could account for both sites in the
mixture of mono-Co(II) forms. A similar EPR signature has
been reported for the di-Co(II) L1 M␤L and was interpreted as
arising from one or two indistinguishable species (7). This signal also resembles that of Co(II)-ImiS, a lactamase that only
bears a DCH site (42).
At Co(II) concentrations over 0.6 eq, a new EPR species
appears, the rhombic species, whereas the intensity of the axial
signal stays steady. At this point, the dinuclear species starts to
accumulate, as indicated by the appearance of a parallel mode
signal corresponding to two spin-coupled Co(II) ions. These
observations can be reconciled with the UV-visible and NMR
titration data if we consider the rhombic species to correspond
to one of the metal ions in an uncoupled di-Co(II) species,
whereas the other site, mainly unaltered when the uncoupled
di-Co(II) enzyme is formed, still gives rise to the axial signal.
The NMR titration reveals that two sites are being initially
filled: the DCH site, which retains its structural features along
the whole titration, and the 3H site, which experiences a structural change after the addition of 0.6 Co(II) eq, which is then
preserved until completion of the metal uptake. This phenomenon takes place at the same Co(II)/BcII ratio at which the
coupled di-Co(II) species starts accumulating, as unequivocally
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